Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
<h4>Purpose</h4>Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-α) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER)...
Guardado en:
Autores principales: | Partha K Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J Cohen, Humberto E Bohorquez, Ian Carmody, George Loss, Luis A Balart, Tong Wu, Srikanta Dash |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97b99bc571c9494aaab336ed28b36050 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PNEUMONIA IN PATIENTS WITH LIVER CIRRHOSIS
por: R. V. Kazakova
Publicado: (2013) -
β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Yue-Ming Ling, et al.
Publicado: (2017) -
Adult-onset citrullinaemia type II with liver cirrhosis: A rare cause of hyperammonaemia
por: Chen Pingrun, et al.
Publicado: (2021) -
Distribution of Hepatic Myofibroblasts and Type I and III Collagen in Rat Liver Cirrhosis Induced by Thioacetamide
por: Poonkhum,Raksawan, et al.
Publicado: (2011) -
Epidemiological and clinical characteristics of patients with liver cirrhosis
por: Ludmila Martínez Leyva, et al.
Publicado: (2021)